干燥综合征患者报告结局与临床参数的性别差异
研究纳入405例符合2016 ACR/EULAR分类标准的干燥综合征患者(女性360例,男性45例),比较患者报告结局(PROMs)与临床参数。女性症状起病更早、诊断延迟更长、干燥症状PROMs评分更差、唾液腺功能更低、压痛点数更多;男性肺部和周围神经系统活动更常见。ESSDAI总分及健康相关生活质量无性别差异。
要点
- 女性干燥综合征患者干燥症状负担更重、唾液腺功能更低、压痛点数更多。
- 男性患者肺部和周围神经系统疾病活动更常见。
- 两性健康相关生活质量(HR-QoL)和患者可接受症状状态(PASS)相似。
核心结论
- 女性与男性干燥综合征患者呈现不同的症状体验和疾病表现模式,但干燥综合征对健康相关生活质量的总体影响相似。
研究设计与样本
- 纳入前瞻性RESULT队列或回顾性DiagnoSS登记中临床诊断干燥综合征且符合2016 ACR/EULAR分类标准的连续患者,比较女性与男性患者的PROMs和临床参数。
主要发现
- 405例患者中女性360例(89%)、男性45例(11%);女性症状起病中位年龄37岁 vs 男性51岁,诊断延迟中位5年 vs 3年。
- 女性ESSPRI干燥中位评分7 vs 男性5,UWS<0.1ml/min者占69% vs 44%,压痛点数更多。
- ESSDAI总分无差异,但女性肺部活动占1.7% vs 男性6.7%,周围神经系统活动占3.4% vs 11.1%。
- 眼部检查、SGUS(Hocevar)、活检参数、免疫血清学和损伤(SSDDI)无性别差异。
- HR-QoL(SF-36、EQ-5D-5L指数中位0.76 vs 0.74)和PASS(72% vs 70%)两性可比。
关键数值与推荐
- 符合2016 ACR/EULAR干燥综合征分类标准。
- UWS<0.1ml/min者女性69% vs 男性44%。
- ESSPRI干燥中位评分女性7 vs 男性5。
- EQ-5D-5L指数中位女性0.76 vs 男性0.74;PASS女性72% vs 男性70%。
临床怎么用
- 临床评估干燥综合征时应关注性别差异:女性侧重干燥症状、唾液腺功能和压痛点,男性警惕肺部和周围神经系统受累。
- 尽管症状表现不同,两性健康相关生活质量总体影响相似,治疗目标可兼顾生活质量改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore sex differences in patient-reported outcome measures (PROMs) and clinical parameters in patients with Sjögren's disease (SjD). METHODS: Consecutive patients with clinical diagnosis of SjD, enrolled in the prospective RESULT cohort or retrospective DiagnoSS registry, who fulfilled 2016 ACR/EULAR classification criteria, were included. PROMs evaluating sicca symptoms, fatigue, pain and health-related quality of life (HR-QoL), and clinical parameters including salivary and ocular gland function, salivary gland ultrasound (SGUS) and biopsy outcomes, physical examination results, serological parameters, systemic disease activity and damage were compared between female and male patients. RESULTS: Of the 405 SjD patients, 360 (89%) were female and 45 (11%) were male. Females had earlier onset of symptoms (median 37 vs. 51 years), longer diagnostic delay (5 vs. 3 years), scored worse on PROMs assessing sicca symptoms (e.g. ESSPRI dryness median 7 vs. 5), had lower salivary gland function (SWS, UWS; UWS<0.1ml/min: 69% vs. 44%), and more tender points than male patients. ESSDAI total score did not differ, but female patients less often had pulmonary (1.7% vs. 6.7%) and peripheral nervous system activity (3.4% vs. 11.1%) than male patients. Clinical parameters including ocular tests, SGUS (Hocevar), biopsy parameters, immunological serology and damage (SSDDI) did not differ. HR-QoL (SF-36, EQ-5D-5L: index median 0.76 vs. 0.74) and PASS (72% vs. 70%) were comparable between sexes. CONCLUSION: In this cohort of SjD patients from daily clinical practice, female and male patients showed distinct patterns of experienced symptoms and disease manifestations. The overall impact of SjD on HR-QoL was similar.
引用
- Kokol H, Rebel D, de Wolff L, et al. Sex differences in patient-reported outcome measures and clinical parameters in patients with Sjögren's disease. Semin Arthritis Rheum. 2026. PMID: 41881907. doi:10.1016/j.semarthrit.2026.152960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。